HomeBiotech

Biotech

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Life Sciences Times - April 28, 2026

Biotech

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Life Sciences Times - April 27, 2026

Biotech

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

Life Sciences Times - April 27, 2026

Biotech

4Moving Biotech Secures FDA Fast Track Status for Experimental Knee Osteoarthritis Drug

Life Sciences Times - April 22, 2026

Biotech

PureTech Reports Promising Early Trial Results for Blood Cancer Therapy

Life Sciences Times - April 22, 2026

Biotech

Trailblazers: Vertex CEO Reshma Kewalramani on Leadership, STEM, Diversity, Inclusion and Medicine on Chai With Manju

Life Sciences Times - December 11, 2020 0

Biotech

Cell Isolation/ Separation Market Worth $15.0 Billion by 2025

Life Sciences Times - December 11, 2020 0

Biotech

LifeX Labs, Pittsburgh Life Sciences Greenhouse Teaming up to Fast-track Startups and Innovators

Life Sciences Times - December 7, 2020 0

Biotech

Life Sciences Leaders Optimistic About Funding Prospects but Cautious About Growth Outlook, New Research Finds

Life Sciences Times - December 7, 2020 0

1...87 8889Page 89 of 89

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

April 29, 2026

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

April 29, 2026

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

April 29, 2026

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

April 29, 2026

Biotech

VectorY Therapeutics Cleared to Expand ALS Clinical Trial to Europe and U.K.

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

4Moving Biotech Secures FDA Fast Track Status for Experimental Knee Osteoarthritis Drug

PureTech Reports Promising Early Trial Results for Blood Cancer Therapy

Most Read

Chiesi Group to Acquire KalVista Pharmaceuticals in $1.9 Billion Deal

Strand Therapeutics Names Kunal Bhatia Chief Financial Officer

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

Axoft Raises $55 Million to Expand Brain-Computer Interface Trials and Manufacturing

EDITOR PICKS

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

908 Devices Names Kola Otitoju Chief Business & Strategy Officer, Announces Inducement Grant

THIS WEEK'S STORIES

Veradermics Reports Strong Late-Stage Trial Results for Oral Hair Loss Treatment

Seaport Therapeutics Adds Biotech Leader Sharon Mates to Board

Convergent Therapeutics Appoints Andrew Davis as Chief Business and Strategy Officer

POPULAR CATEGORY

ABOUT US

FOLLOW US